Françoise Berlioz

416 total citations
9 papers, 326 citations indexed

About

Françoise Berlioz is a scholar working on Oncology, Pharmacology and Infectious Diseases. According to data from OpenAlex, Françoise Berlioz has authored 9 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Pharmacology and 2 papers in Infectious Diseases. Recurrent topics in Françoise Berlioz's work include Drug Transport and Resistance Mechanisms (5 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Françoise Berlioz is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Françoise Berlioz collaborates with scholars based in France, United States and Netherlands. Françoise Berlioz's co-authors include C Rozé, Marc Laburthe, Annick Tsocas, Marion Buyse, André Bado, Gabriel Péranzi, Sandra Guilmeau, Miguel J.M. Lewin, Thierry Voisin and Didier Merlin and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Françoise Berlioz

9 papers receiving 319 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Françoise Berlioz 118 99 91 65 59 9 326
Norma Lister 98 0.8× 63 0.6× 147 1.6× 13 0.2× 36 0.6× 10 373
Lydia Gil Huerta 34 0.3× 44 0.4× 48 0.5× 24 0.4× 71 1.2× 13 345
Hiroshi Ogihara 169 1.4× 22 0.2× 54 0.6× 25 0.4× 29 0.5× 7 326
U. Ritzel 92 0.8× 113 1.1× 84 0.9× 125 1.9× 67 1.1× 12 390
Jin Shimakura 184 1.6× 47 0.5× 33 0.4× 8 0.1× 51 0.9× 11 397
Hong Y. Zhang 23 0.2× 41 0.4× 47 0.5× 113 1.7× 43 0.7× 7 337
H. Carlier 94 0.8× 18 0.2× 229 2.5× 33 0.5× 152 2.6× 42 540
Alicia L. Carreiro 20 0.2× 31 0.3× 70 0.8× 35 0.5× 152 2.6× 5 382
MASUMI KADOWAKI 97 0.8× 10 0.1× 56 0.6× 65 1.0× 57 1.0× 28 402

Countries citing papers authored by Françoise Berlioz

Since Specialization
Citations

This map shows the geographic impact of Françoise Berlioz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Françoise Berlioz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Françoise Berlioz more than expected).

Fields of papers citing papers by Françoise Berlioz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Françoise Berlioz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Françoise Berlioz. The network helps show where Françoise Berlioz may publish in the future.

Co-authorship network of co-authors of Françoise Berlioz

This figure shows the co-authorship network connecting the top 25 collaborators of Françoise Berlioz. A scholar is included among the top collaborators of Françoise Berlioz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Françoise Berlioz. Françoise Berlioz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Buyse, Marion, Françoise Berlioz, Sandra Guilmeau, et al.. (2001). PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine. Journal of Clinical Investigation. 108(10). 1483–1494. 18 indexed citations
2.
Buyse, Marion, Françoise Berlioz, Sandra Guilmeau, et al.. (2001). PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine. Journal of Clinical Investigation. 108(10). 1483–1494. 177 indexed citations
3.
Berlioz, Françoise, Jean-José Maoret, Hervé Paris, et al.. (2000). α2-Adrenergic Receptors Stimulate Oligopeptide Transport in a Human Intestinal Cell Line. Journal of Pharmacology and Experimental Therapeutics. 294(2). 466–472. 17 indexed citations
4.
Buyse, Marion, Françoise Berlioz, Sandra Guilmeau, et al.. (2000). Intestinal epithelial cells express leptin receptors that modulate the oligopeptide transporter Pept-1. Gastroenterology. 118(4). A604–A604. 3 indexed citations
5.
Berlioz, Françoise, J.J. Maoret, H. Paris, et al.. (2000). alpha(2)-adrenergic receptors stimulate oligopeptide transport in a human intestinal cell line.. PubMed. 294(2). 466–72. 44 indexed citations
6.
Berlioz, Françoise, S. Julien, Annick Tsocas, et al.. (2000). Chronic Nifedipine Dosing Enhances Cephalexin Bioavailability and Intestinal Absorption in Conscious Rats. Drug Metabolism and Disposition. 28(11). 1267–1269. 8 indexed citations
7.
Berlioz, Françoise, Sylvie Julien, Annick Tsocas, et al.. (1999). Neural Modulation of Cephalexin Intestinal Absorption Through the Di- and Tripeptide Brush Border Transporter of Rat Jejunum In Vivo. Journal of Pharmacology and Experimental Therapeutics. 288(3). 1037–1044. 26 indexed citations
8.
Berlioz, Françoise, et al.. (1998). Intestinal absorption of saquinavir in the rat: Insights in possible mechanisms. Gastroenterology. 114. A957–A957. 1 indexed citations
9.
POIRIER, J.‐M., Françoise Berlioz, F Isnard, & G Cheymol. (1996). Marked intra- and inter-patient variability of itraconazole steady state plasma concentrations.. PubMed. 51(2). 163–7. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026